Medications for social anxiety disorder
Pro Research Analysisby 
Searched over 200M research papers
First-Line Medications for Social Anxiety Disorder: SSRIs and SNRIs
Selective serotonin reuptake inhibitors (SSRIs) are widely recognized as the first-line pharmacological treatment for social anxiety disorder (SAD) due to their strong evidence base, safety, and tolerability. SSRIs such as paroxetine, sertraline, fluoxetine, and escitalopram have consistently shown effectiveness in reducing social anxiety symptoms and are also helpful for common comorbid conditions like depression 1234+4 MORE. Serotonin-norepinephrine reuptake inhibitors (SNRIs), particularly venlafaxine, are also effective and are considered alongside SSRIs as first-line options 46710.
Other Effective Medication Classes: MAOIs, Benzodiazepines, and Anticonvulsants
Monoamine oxidase inhibitors (MAOIs), such as phenelzine, have demonstrated strong efficacy for SAD, sometimes with larger effect sizes than SSRIs, but are generally reserved for cases that do not respond to safer medications due to their side effect profile and dietary restrictions 1234+3 MORE. Reversible inhibitors of monoamine oxidase A (RIMAs), like brofaromine, also show benefit, though the evidence is less robust 1234+1 MORE.
Benzodiazepines, including clonazepam and bromazepam, have shown efficacy in some studies, but concerns about dependence and side effects limit their use to specific situations or as augmentation for non-responders 1234+3 MORE. Anticonvulsants such as gabapentin have also demonstrated benefit in some trials, but more research is needed to confirm their role 1234+2 MORE.
Medications with Limited or No Evidence: Beta-Blockers
Beta-blockers are sometimes used for performance anxiety, but current evidence does not support their effectiveness for the broader symptoms of social anxiety disorder .
Medication Use in Children and Adolescents
For children and adolescents, SSRIs are the only class of drugs shown to be superior to placebo for both anxiety reduction and treatment response, but they are associated with higher rates of side effects, including gastrointestinal symptoms and suicidal ideation. SNRIs like venlafaxine have also shown some efficacy. Due to the risk of side effects, guidelines recommend that medication should not be routinely offered to children and adolescents unless symptoms are severe or psychotherapy has not been effective .
Duration of Treatment and Relapse Prevention
Longer-term use of medication is valuable for maintaining treatment response and preventing relapse in individuals who benefit from pharmacotherapy. Discontinuing medication after 12–20 weeks is associated with a higher risk of relapse compared to continued treatment 347.
Combining Medication with Psychotherapy
Cognitive-behavioral therapy (CBT) is a well-established alternative or adjunct to medication and may be especially helpful for those who do not respond fully to pharmacotherapy. For adults who decline psychological intervention, SSRIs remain the most consistent pharmacological option 410.
Considerations for Treatment-Resistant Cases
For patients who do not respond to first-line SSRIs or SNRIs, options include augmentation with benzodiazepines or gabapentin, or switching to MAOIs, RIMAs, or other agents. However, evidence for these strategies is limited, and clinical judgment is important 147.
Conclusion
SSRIs and SNRIs are the most effective and well-tolerated medications for social anxiety disorder and are recommended as first-line treatments. MAOIs, RIMAs, benzodiazepines, and anticonvulsants may be considered in specific cases, especially when first-line treatments are ineffective or not tolerated. In children and adolescents, medication should be used cautiously and typically only when psychotherapy is insufficient. Long-term treatment helps prevent relapse, and combining medication with psychotherapy can improve outcomes for many patients.
Sources and full results
Most relevant research papers on this topic